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INTRODUCTION
Capsaicin is the spice extract of red peppers and is easily in-
haled, causing a dose-dependent and reproducible cough.
1 In 
the laboratory, capsaicin is often used to measure the sensitivi-
ty of the cough reflex. It is also one of the most widely used sea-
sonings in Korea. Occupational rhinitis (OR) is two to four times 
more common than occupational asthma (OA)
2 and may be a 
risk factor for developing OA, although the contribution of work-
place exposure to the general burden of rhinitis remains un-
known.
3 To date, there has been no published report of OR 
caused by capsaicin. Here, we describe for the first time a case 
of capsaicin-induced OR confirmed by a nasal provocation test 
in a mill worker.
CASE REPORT
A 44-year-old female visited our allergy clinic for progressive 
nasal congestion, rhinorrhea, and itchy nose. She had no histo-
ry of allergic diseases or chronic medical illness. She had worked 
at a mill for 7 years, grinding red pepper; during that time, she 
was exposed to red pepper powder. Her rhinitis symptoms de-
veloped 4 years after starting her job; she had no symptoms pri-
or to the job. Her symptoms began at the start of each work day, 
were more aggravated upon exposure to red pepper powder, 
and subsided once outside of the workplace. At presentation, 
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blood cell differential count, serum biochemistry, total IgE (48 
kU/L), and chest and paranasal sinus radiographs were normal. 
Nasal endoscopic findings included inferior turbinate hyper-
trophy with swollen mucosa; there was no evidence of nasal 
polyps or any other paranasal sinus disease. The patient had 
negative responses to all common inhalant allergens (Bencard, 
Bradford, UK), including capsaicin (0.1, 1, 10 mg/mL; Sigma-
Aldrich, St. Louis, MO, USA), as determined by skin prick tests. 
Eosinophils were not present in the patient’s sputum or nasal 
smear samples collected at her initial visit.
Nasal provocation tests with nasal lavage were performed us-
ing capsaicin allergen. Nasal symptom scores and eosinophil 
counts in the nasal lavage fluid at 10 minutes, 30 minutes, 1 
hour, and 3 hours after the provocation test were compared 
with the baseline values measured before the provocation test. 
After 10 minutes of exposure to 0.1 μM capsaicin, the patient’s 
nasal symptom score increased and was maintained until 30 
minutes, at which point the symptom score decreased; no late 
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response was observed. Eosinophil counts in the nasal lavage 
fluid increased at 10 minutes, was maintained until 30 minutes, 
and had decreased at the 1 and 3 hours time points (Fig. 1). The 
volume and minimum cross-sectional area of the nasal cavity, 
measured by acoustic rhinometry (ARS 1003; SGS, North Mi-
ami Beach, FL, USA), decreased by >25% from 10 minutes un-
til 1 hour after nasal provocation (Fig. 2). As a control, the patient 
had a negative response to nasal provocation with Derma-
tophagoides farinae allergen (i.e., house dust mites). There were 
no significant changes in the levels of four inflammatory medi-
ators, i.e., vascular endothelial growth factor (VEGF), granulo-
cyte-macrophage colony-stimulating factor (GM-CSF), inter-
leukin-8 (IL-8), and substance P (SP), in the nasal lavage fluid 
during the nasal provocation test (Table). 
The final diagnosis was OR caused by capsaicin. The patient’s 
rhinitis improved after she transferred out of her workplace and 
started treatment with antihistamines and intranasal cortico-
steroids. 
DISCUSSION
Occupational allergic diseases such as OR are common, and 
their prevalence among the workforce is on the rise. Cross-sec-
tional studies have determined that the incidence of OR caused 
by high-molecular-weight agents such as animal-derived aller-
gens, grain dust, and biological enzymes ranges from 2% to 87%, 
and the incidence of OR caused by low-molecular-weight agents 
such as diisocyanates, anhydrides, drugs, and chemicals ranges 
from 3% to 48%.
2,3 OR and other allergic diseases have profound 
effects on workers, resulting in performance deficits, reduced 
productivity, and psychosocial problems.
1 In our study, the pa-
tient developed OR symptoms 4 years after starting her pepper 
mill job. Nasal provocation tests with capsaicin were positive, 
with increased eosinophils in the nasal lavage fluid, while the 
control provocation test with house dust mite allergen was neg-
ative. Therefore, we concluded that the patient had OR caused 
by capsaicin exposure from her workplace.
Capsaicin is a neurotoxin capable of stimulating and/or de-
sensitizing sensory neuron C-fibers by activating the transient 
potential receptor vanilloid 1 (TRPV1).
4 In animal models, cap-
saicin releases neuropeptides and induces neurogenic inflam-
mation, including vasodilation and plasma extravasation.
5 
However, most clinical studies have shown that capsaicin pro-
vokes a secretory response in the absence of vascular permea-
bility,
3,6 and there is no direct evidence of the release of neuro-
peptides such as SP, calcitonin gene-related peptide, or vasoac-
tive intestinal peptide in human nasal mucosa.
7
Neuropeptides induce neutrophil adhesion, stimulate the 
proliferation of human T lymphocytes, and increase inflamma-
Fig. 1.  Changes in the nasal symptom score and eosinophil count in the nasal 
lavage fluid collected from our patient during the nasal provocation test with 
capsaicin.
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Fig. 2.  Changes in the volume (vol) and minimum cross-sectional area (MCA) 
of the patient’s nasal cavity, as measured by acoustic rhinometry, during the na-
sal provocation test with capsaicin. 
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Table.  Laboratory data of the nasal lavage fluid collected from our patient dur-
ing nasal provocation tests with capsaicin and Dermatophagoides farinae aller-
gen
Nasal
provocation test
Concentration* (pg/mL) Total 
protein 
(µg/mL) VEGF IL-8 GM-CSF Substance P
Capsaicin Basal 89.193 UD  1.075 UD 23.7
10 min 16.591 UD 0.005 UD 57.4
30 min 46.527 UD UD UD 41.9
1 hr 71.767 UD 0.479 UD 28.7
3 hr 119.872 UD 1.800 UD 71.7
House
dust mite  
(D. farinae)
Basal 102.637 UD 0.756 UD 45.8
10 min 42.194 UD 0.530 UD 23.9
30 min 75.434 UD 0.306 UD 40.8
1 hr 48.942 UD UD UD 19.0
3 hr 76.36 UD UD UD 33.2
*As measured by enzyme-linked immunosorbent assay; VEGF, vascular endo-
thelial growth factor; IL-8, interleukin-8; GM-CSF, granulocyte-macrophage col-
ony-stimulating factor; UD, undetectable.Nam et al.
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tory cytokines.
7 Therefore, the leukocyte influx induced by cap-
saicin may be a nonspecific inflammatory cellular response,
8 
although it is unclear whether neurogenic inflammation actu-
ally occurs in human subjects.
9,10 One study concluded that 
capsaicin caused nasal symptoms and glandular stimulation, 
without evidence of increased vascular permeability or mast 
cell activation.
11 More recent studies have suggested that C-fi-
bers themselves, not TRPV1, play a role in allergic airway in-
flammation.
12,13 Capsaicin has also been demonstrated to have 
TRPV1-independent effects, including ion channel activity
14 
and calcium influx.
15 Calcium is a powerful stimulus for cell ac-
tivation and is critical in regulating cellular activities. In a few 
studies, capsaicin nasal challenge resulted in neurogenic in-
flammation in patients with allergic rhinitis.
16,17 In the present 
study, a nasal provocation test with capsaicin induced symptom 
development and an immediate increase in eosinophils in the 
nasal lavage fluid, whereas allergy skin tests with capsaicin so-
lution were negative. Furthermore, epithelial cell-derived cyto-
kines such as GM-CSF, VEGF, IL-8, and SP were not detected in 
the nasal lavage fluid collected during the nasal provocation 
test with capsaicin or house dust mite allergen. We cannot spec-
ulate about the mechanism of eosinophil activation after cap-
saicin exposure in this patient, but a non-IgE mediated response 
may be involved. 
In conclusion, we report the first published case of OR induced 
by capsaicin, as confirmed by a nasal provocation test, in a pep-
per mill worker.
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